Shin DM - Search Results

1

Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.

Shin DM, Mao L, Papadimitrakopoulou VM, Clayman G, El-Naggar A, Shin HJ, Lee JJ, Lee JS, Gillenwater A, Myers J, Lippman SM, Hittelman WN, Hong WK. Shin DM, et al. Among authors: shin hj. J Natl Cancer Inst. 2000 Jan 5;92(1):69-73. doi: 10.1093/jnci/92.1.69. J Natl Cancer Inst. 2000. PMID: 10620636 Clinical Trial. No abstract available.

2

p53 and retinoid chemoprevention of oral carcinogenesis.

Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, Hittelman WN, Hong WK. Lippman SM, et al. Among authors: shin dm. Cancer Res. 1995 Jan 1;55(1):16-9. Cancer Res. 1995. PMID: 7805028 Clinical Trial.

3

Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues.

Xu XC, Ro JY, Lee JS, Shin DM, Hong WK, Lotan R. Xu XC, et al. Among authors: shin dm. Cancer Res. 1994 Jul 1;54(13):3580-7. Cancer Res. 1994. PMID: 8012985

4

Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.

Shin DM, Voravud N, Ro JY, Lee JS, Hong WK, Hittelman WN. Shin DM, et al. J Natl Cancer Inst. 1993 Jun 16;85(12):971-8. doi: 10.1093/jnci/85.12.971. J Natl Cancer Inst. 1993. PMID: 8098774

5

Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis.

Shin DM, Ro JY, Hong WK, Hittelman WN. Shin DM, et al. Cancer Res. 1994 Jun 15;54(12):3153-9. Cancer Res. 1994. PMID: 8205534

6

Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.

Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK, Hittelman WN. Shin DM, et al. Cancer Res. 1994 Jan 15;54(2):321-6. Cancer Res. 1994. PMID: 8275461

7

Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.

Voravud N, Shin DM, Ro JY, Lee JS, Hong WK, Hittelman WN. Voravud N, et al. Among authors: shin dm. Cancer Res. 1993 Jun 15;53(12):2874-83. Cancer Res. 1993. PMID: 8504429

8

p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.

Shin DM, Lee JS, Lippman SM, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJ, Ro JY, Goepfert H, Hong WK, Hittelman WN. Shin DM, et al. Among authors: shin hj. J Natl Cancer Inst. 1996 Apr 17;88(8):519-29. doi: 10.1093/jnci/88.8.519. J Natl Cancer Inst. 1996. PMID: 8606380

9

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, Lawhorn K, Gillenwater AM, Ang KK, Clayman GL, Callender DL, Hong WK, Lippman SM. Shin DM, et al. J Clin Oncol. 1998 Apr;16(4):1325-30. doi: 10.1200/JCO.1998.16.4.1325. J Clin Oncol. 1998. PMID: 9552033 Clinical Trial.

10

Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman SM. Shin DM, et al. Semin Oncol. 1998 Apr;25(2 Suppl 4):40-4; discussion 45-8. Semin Oncol. 1998. PMID: 9578061 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

853 results

Search Page

Filters